|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash flows from operating activities | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | ||
| Provision for warranty costs | ||
| Change in fair value of warrants and loan commitment | ||
| Amortization of debt discount | ||
| Amortization of right-of-use assets | ||
| Stock-based compensation | ||
| Provision for excess and obsolete inventories | ||
| Provision for bad debt | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable | ||
| Inventories | ||
| Prepaid expenses and other current assets | ||
| Other assets | ||
| Operating lease right-of-use assets | ||
| Accounts payable | ||
| Accrued expenses and other current liabilities | ||
| Deferred revenue | ||
| Operating lease obligations | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities | ||
| Purchases of property and equipment | ||
| Purchases of license | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities | ||
| Proceeds from issuance or exercise of preferred stock | ||
| Series A-2 | ||
| Series C-2 | ||
| Series D | ||
| Preferred stock issuance costs | ||
| Proceeds from initial public offering of common stock, net of underwriting fees of $8,750 | ||
| Proceeds received from borrowings on credit agreement | ||
| Initial public offering costs paid | ||
| Debt issuance cost paid | ||
| Exercise of common stock options | ||
| Net cash provided by financing activities | ||
| Net change in cash | ||
| Effect of exchange rate changes on cash and cash equivalents | ||
| Net change in cash and cash equivalents | ||
| Cash and cash equivalents at beginning of period | ||
| Cash and cash equivalents at end of period | ||
| Non-cash investing and financing activities | ||
| Transfer of Tranche B loan commitment to contra-debt upon additional borrowing under credit agreement | ||
| Tranche C Term Loan | ||
| Tranche D Term Loan | ||
| Tranche B Term Loan | ||
| Total transfer of Tranche B loan commitment to contra-debt upon additional borrowing under credit agreement | ||
| Exercise of Series A-2 preferred stock warrants | ||
| Conversion of redeemable convertible preferred stock to common stock upon closing of the initial public offering (including $24.7 million of accrued dividends) | ||
| Conversion of preferred stock warrants to common stock warrants | ||
| Fair value of warrants issued with credit agreement | ||
| Fair value of loan commitment | ||
| Increase in operating lease right-of-use assets | ||
| Increase in operating lease obligations | ||
| Supplemental disclosure of cash flow information | ||
| Cash paid for interest |
Loading...
